Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.

Fagerlund B, Søholm B, Fink-Jensen A, Lublin H, Glenthøj BY.

Clin Neuropharmacol. 2007 Jan-Feb;30(1):3-12.

PMID:
17272964
[PubMed - indexed for MEDLINE]
2.

A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.

Lee BJ, Lee JG, Kim YH.

J Psychopharmacol. 2007 Jun;21(4):421-7. Epub 2006 Nov 8.

PMID:
17092979
[PubMed - indexed for MEDLINE]
3.

A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia.

Tuğal O, Yazici KM, Anil Yağcioğlu AE, Göğüş A.

Int J Neuropsychopharmacol. 2004 Jun;7(2):117-23. Epub 2004 Jan 23.

PMID:
14741060
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.

Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R.

Neuropsychopharmacology. 2008 May;33(6):1217-28. Epub 2007 Jul 11.

PMID:
17625502
[PubMed - indexed for MEDLINE]
Free Article
5.

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.

Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.

Neurology. 2009 May 5;72(18):1555-61. doi: 10.1212/01.wnl.0000344650.95823.03. Epub 2009 Jan 28.

PMID:
19176895
[PubMed - indexed for MEDLINE]
6.

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.

Friedman JI, Adler DN, Howanitz E, Harvey PD, Brenner G, Temporini H, White L, Parrella M, Davis KL.

Biol Psychiatry. 2002 Mar 1;51(5):349-57.

PMID:
11904128
[PubMed - indexed for MEDLINE]
7.

A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.

Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.

Bipolar Disord. 2006 Feb;8(1):75-80.

PMID:
16411983
[PubMed - indexed for MEDLINE]
8.

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.

Neurology. 2004 Aug 24;63(4):651-7.

PMID:
15326237
[PubMed - indexed for MEDLINE]
9.

Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.

Risch SC, Horner MD, McGurk SR, Palecko S, Markowitz JS, Nahas Z, DeVane CL.

Schizophr Res. 2007 Jul;93(1-3):131-5. Epub 2007 Mar 27.

PMID:
17391930
[PubMed - indexed for MEDLINE]
10.

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.

Akhondzadeh S, Gerami M, Noroozian M, Karamghadiri N, Ghoreishi A, Abbasi SH, Rezazadeh SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1810-5. doi: 10.1016/j.pnpbp.2008.08.001. Epub 2008 Aug 7.

PMID:
18727948
[PubMed - indexed for MEDLINE]
11.

Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial.

Freudenreich O, Herz L, Deckersbach T, Evins AE, Henderson DC, Cather C, Goff DC.

Psychopharmacology (Berl). 2005 Sep;181(2):358-63. Epub 2005 Oct 14.

PMID:
15778880
[PubMed - indexed for MEDLINE]
12.

Efficacy and tolerability of low-dose donepezil in schizophrenia.

Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):179-84.

PMID:
16062097
[PubMed - indexed for MEDLINE]
13.

Donepezil preserves cognition and global function in patients with severe Alzheimer disease.

Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.

Neurology. 2007 Jul 31;69(5):459-69.

PMID:
17664405
[PubMed - indexed for MEDLINE]
14.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
[PubMed - indexed for MEDLINE]
15.

Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.

Mazeh D, Zemishlani H, Barak Y, Mirecki I, Paleacu D.

Int Psychogeriatr. 2006 Sep;18(3):429-36. Epub 2006 Feb 15.

PMID:
16478570
[PubMed - indexed for MEDLINE]
16.

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.

Aarsland D, Laake K, Larsen JP, Janvin C.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):708-12. Erratum in: J Neurol Neurosurg Psychiatry 2002 Sep;73(3):354.

PMID:
12023410
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.

Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group.

Arch Neurol. 2001 Mar;58(3):427-33.

PMID:
11255446
[PubMed - indexed for MEDLINE]
18.

Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.

Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, Grupper D, Buchman N, Kotler M, Rabey JM, Weizman A.

Hum Psychopharmacol. 2004 Jul;19(5):343-6.

PMID:
15252826
[PubMed - indexed for MEDLINE]
19.

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

Nahas Z, George MS, Horner MD, Markowitz JS, Li X, Lorberbaum JP, Owens SD, McGurk S, DeVane L, Risch SC.

Neurocase. 2003 Jun;9(3):274-82.

PMID:
12925933
[PubMed - indexed for MEDLINE]
20.

Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.

Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM.

AJNR Am J Neuroradiol. 2009 Feb;30(2):411-6. doi: 10.3174/ajnr.A1359. Epub 2008 Nov 11.

PMID:
19001543
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk